Construction and Expression of Vector withmip/flaA Advantages Epitope Genes ofLegionella pneumophila

HE Jin-lei, PENG Ran, ZHang Jun-rong. et al

Abstract

To generate and express fusion vector withmip/flaAadvantages epitope genes of Legionella pneumophila by select mip and flaAadvantages epitope genes for future research onLegionella pneumophilaprotein vaccine. Methods Following analysis of secondary structure and surface properties such as: physical and chemical properties, hydropathy, plasticity, antigen index and extracellular domain of Mip and FlaA proteins by bioinformatics methods, the region which active epitope may exist was selected as advantages epitope region. Then, the recombinant plasmid pET-mip, pET-flaA and pET-mip/flaA with advantages epitope genes were constructed by PCR amplification andT4ligase connection, and induced the expression in E.coli. Results Many potential antigenic epitopes in Mip and FlaA were identified, and the selected advantages epitope regions were cloned and expressed successfully. Moreover, themip/flaAtwo advantages associated epitope fusion proteins were also successfully expressed. Conclusion DNA Star software and Expasy online analysis system can successfully predict antigenic epitopes forLegionella pneumophila Mip and FlaA. And prokaryotic expression vector pET-mip/flaAwith advantages epitope genes has been successfully constructed and efficiently expressed.

Keywords: Legionella pneumophila, Advantages epitope mip gene fla, A gene, Fusion expression 

 

Full Text:

PDF


References


Newton HJ, Ang DK, van Driel IR, et al. Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev,2010;23(2) :274-298.

Gomez-Valero L, Rusniok C, Rolando M, et al. Comparative analyses of Legionella species identifies genetic features of strains causing Legionnaires’ disease. Genome Biol, 2014; 15 : 505.

Ditommaso S, Giacomuzzi M, Rivera SK.et al. Virulence ol Legionella pneumophila strains isolated from hospital water system and healthcare-associated Legionnaires, disease in Northern Italy between 2004 and 2009. BMC Infect Dis,2014; 14:483. doi; 10. 1186/1471-2334-14-483.

Jiang G, Charoenvit Y, Moreno A, et al. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malar J, 2007 $6:135.

Heppner DG Jr, Kester KE, Ockenhouse CF, et al. Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria; progress at the Walter Reed Army Institute of Research. Vaccine,2005;23( 17-18):2243-2250.

Sharon J, Rynkiewicz MJ, Lu Z, et al. Discovery of protective В-cell epitopes for development of antimicrobial vaccines and antibody therapeutics. Immunology,2014; 142( 1): 1-23.

Xu Y, Guan W, Xu JN, et al. Evaluation of the protective immunity of the Legionella pneumophila recombinant protein FlaA/MompS/PilE in an A/J mouse model. Vaccine, 2011; 29 (23):4051-4057.

Burton DR. Poignard P. Stanfield RL, et al. Broadly neutralizing antibodies suggest new prospects to counter highly antigenically diverse viruses. Science, 2012; 337 ( 6091 ); 183- 186.

Delfani S, Imani Fooladi AA, Mobarez AM, et al. In sitico analysis lor identifying potential vaccine candidates against Staphylococcus aureus. Clin Exp Vaccine Res. 2015; 4 (1) ; 99- 106.

Ceymann A, Horstmann M, Ehses P. et al. Solution structure of the Legionella pneumophila Mip-rapamycin complex. BMC Struct Biol,2008;8:17. doi; 10. 1186/1472-6807-8-17.

Kohler R. Fanghonel J, Konig B, et al. Biochemical and functional analyses of the Mip protein: influence of the N- terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila. Infect Immun, 2003; 71 (8):4389-4397.

Ricci ML, Torosantucci A, Scaturro M, et al. Induction of protective immunity by Legionella pneumophila flagellum in an A/J mouse model. Vaccine,2005;23(40) :4811-4820.

Pereira MS, Morgantetti GF, Massis LM. et al. Activation of NLRC4 by flagellated bacteria triggers caspase-1 -dependent and -independent responses to restrict Legionella pneumophila replication in macrophages and in -vivo. J Immunol,2011; 187(12):6447-6455.

XuJN, Yang ZW, Chen JP, et al. Protective immunity against Legionnaires’ disease in an A/J mouse model using a DNA vaccine composed of an outer membrane protein (29 kDa) and the PilE fusion protein. Diagn Microbiol Infect Dis,2012;73 (1 ) : 9-15.


Refbacks

  • There are currently no refbacks.